Effectiveness of Intravenous Immunoglobulin Therapy for Skin Disease Other Than Toxic Epidermal Necrolysis: A Retrospective Review of Mayo Clinic Experience
- Editorial. // Acta Dermato-Venereologica;Nov2003, Vol. 83 Issue 6, p402
This article discusses the value of immunoglobulin therapy in dermatology. High-dose intravenous immunoglobulin therapy (HDIVIG) has recently entered dermatology and is used in selected cases, when the usual immunosuppressive therapy fails. HDIVIG is a very expensive treatment and not without...
- Toxic epidermal necrolysis-like acute cutaneous lupus erythematosus. Paradela, S.; Mart�nez-G�mez, W.; Fern�ndez-Jorge, B.; Casti�eiras, I.; Yebra-Pimentel, T.; Llinares, P.; Capdevila, E. Fonseca // Lupus;2007, Vol. 16 Issue 9, p741
The term ï¿½Acute Syndrome of Apoptotic Pan-Epidermolysisï¿½ (ASAP) designs clinical entities characterized by massive cleavage of the epidermis resulting from hyperacute epidermal basal cell apoptotic injury. It can be seen typically in classic toxic epidermal necrolysis (TEN), but...
- High-dose Intravenous Immunoglobulin for Severe Drug Reactions: Efficacy in Toxic Epidermal Necrolysis. Campione, Elena; Marulli, Georgiana Clare; Carrozzo, Anna Maria; Chimenti, Maria Sole; Costanzo, Antonio; Bianchi, Luca // Acta Dermato-Venereologica;Nov2003, Vol. 83 Issue 6, p430
High-dose intravenous immunoglobulin has been proposed as an alternative treatment for several immuno-mediated inflammatory skin diseases, usually at a dosage of 1-2 g/kg. We describe the treatment of 10 patients affected by toxic epidermal necrolysis using 400 mg/kg per day on 5 consecutive...
- INTRAVENOUS IMMUNOGLOBULIN IN DERMATOLOGY. Dhar, Sandipan // Indian Journal of Dermatology;Jan-Mar2009, Vol. 54 Issue 1, p77
The article discusses the application of intravenous immunoglobulin (i.v. IG) in dermatology. It explains that an i.v. IG is a sterile highly purified immunoglobulin G preparation that was developed from pooled human plasma and consists of over 95% of unmodified IgG. One study reported the...
- The efficacy of intravenous immunoglobulin for the treatment of toxic epidermal necrolysis: a systematic review and meta-analysis. // Current Medical Literature: Dermatology;2012, Vol. 17 Issue 4, p110
A review of the article "The efficacy of intravenous immunoglobulin for the treatment of toxic epidermal necrolysis: a systematic review and meta-analysis," by Y. C. Huang which appeared in the "British Journal of Dermatology" is presented.
- Toxic Epidermal Necrolysis (Scalded Skin Syndrome): Report of Two Cases. Baird, Robert L.; Reichelderfer, Thomas E. // Clinical Pediatrics;Jan1963, Vol. 2 Issue 1, p16
Reports on cases of children with toxic epidermal necrolysis. Literature review on the disease; Diagnosis of a thermal burn on a 23-month-old female; Blister on a two-and-one-half-year-old Negro boy.
- Toxic Epidermal Necrolysis (TEN). Vohr, Hans-Werner // Encyclopedic Reference of Immunotoxicology;2005, p651
The entry offers information on toxic epidermal necrolysis (TEN). It is a febrile mucocutaneous syndrome characterized by full-thickness sloughing of the epidermis. Similarities exist between Stevens-Johnson syndrome and TEN in terms of histopathology and responsible drugs.
- Toxic Epidermal Necrolysis (TEN; Ritter's Disease) and Staphylococcal Scalded Skin Syndrome (SSSS). Koblenzer, Peter J. // Clinical Pediatrics;Aug1976, Vol. 15 Issue 8, p724
Focuses on toxic epidermal necrolysis and staphylococcal scalded skin syndrome. History of the disease.
- Drug-Related Disease is Deadly. Shovlin, Joseph P. // Review of Optometry;6/15/2001, Vol. 138 Issue 6, p111
Discusses the key features of toxic epidermal necrolysis. Desquamation of a large area of the skin; Prevention of cytotoxic reactions to drugs; Presence of ocular complications; Reduction of the risk of death.